Coverage
-
September 17, 2015
A spinal patient has asked the U.S. Supreme Court to review a Tenth Circuit ruling that her injury claims over Medtronic Inc.'s Infuse bone graft device are pre-empted despite them involving off-label uses not approved by the U.S. Food and Drug Administration, saying the decision created a circuit split.
5 other articles on this case.
View all »